5 Best Small Cap Pharma Stocks to Invest In

Page 5 of 5

1. Dynavax Technologies Corporation (NASDAQ:DVAX)

Number of Hedge Fund Investors In Q4 2023: 28

Dynavax Technologies Corporation (NASDAQ:DVAX) develops vaccine for Hepatitis B. Its latest earnings report in February 2024 led to the shares jumping by 2% in aftermarket, with Dynavax Technologies Corporation (NASDAQ:DVAX) announcing that revenue for its unique Hepatitis B vaccine had jumped by 69% annually in 2023 to sit at $213 million.

28 out of the 933 hedge funds covered by Insider Monkey’s Q4 2023 research had bought Dynavax Technologies Corporation (NASDAQ:DVAX)’s shares. David Kroin’s Deep Track Capital was the biggest shareholder as it owned $99.1 million worth of shares.

Follow Dynavax Technologies Corp (NASDAQ:DVAX)

Disclosure: None. You can also take a look at 11 Best Small-Cap Growth Stocks to Invest In and Top 20 Most Valuable Travel Companies in the World.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Follow Insider Monkey on Twitter

Page 5 of 5